¹Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
²Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
³Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. Electronic address: berch001@mc.duke.edu.
⁴Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
⁵Comprehensive Cancer Center The Netherlands, Utrecht, The Netherlands; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands.
⁶Landspitali University Hospital, Reykjavik, Iceland; University of Iceland, School of Medicine, Reykjavik, Iceland.
⁷Department of Clinical Genetics, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
⁸Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
⁹Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada; Ontario Cancer Genetics Network, Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
¹⁰Department of Epidemiology, University of California Irvine, Irvine, CA, USA.
¹¹N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
¹²Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹³Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
¹⁴Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
¹⁵Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein, University Kiel, Kiel, Germany.
¹⁶Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Clinical Cancer Genetics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
¹⁷Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
¹⁸Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
¹⁹Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
²⁰Western Sydney and Nepean Blue Mountains Local Health Districts, Westmead Millennium Institute for Medical Research, University of Sydney, Sydney, Australia.
²¹Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
²²Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
²³Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR, USA; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
²⁴Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany.
²⁵University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany.
²⁶Centro Nacional de Genotipación, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
²⁷Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
²⁸Sheba Medical Center, Tel Aviv, Israel.
²⁹Multidisciplinary Breast Center, University Hospital Leuven, University of Leuven, Belgium.
³⁰Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
³¹Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway.
³²Department of Oncology, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland.
³³Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
³⁴Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
³⁵Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
³⁶Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
³⁷Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy.
³⁸Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
³⁹Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴⁰Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
⁴¹Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
⁴²Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada.
⁴³Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
⁴⁴Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI-Catalan Institute of Oncology, Girona, Spain.
⁴⁵Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany.
⁴⁶Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
⁴⁷Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA.
⁴⁸Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴⁹Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
⁵⁰Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
⁵¹Section of Genetic Oncology, Department of Laboratory Medicine, University Hospital of Pisa, University of Pisa, Pisa, Italy.
⁵²Cancer Genetics Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia; Department of Pathology, University of Melbourne, Melbourne, VIC, Australia.
⁵³Gynaecological Oncology, The Chris O'Brien Lifehouse and The University of Sydney, Sydney, Australia.
⁵⁴Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁵⁵Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
⁵⁶Center for Medical Genetics, Ghent University, Ghent, Belgium.
⁵⁷Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
⁵⁸Division of Epidemiology and Biostatistics, University of New Mexico, Albuquerque, NM, USA.
⁵⁹Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA; Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA.
⁶⁰Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, UK.
⁶¹Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA, USA; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
⁶²Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK.
⁶³Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA.
⁶⁴International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical Academy, Szczecin, Poland.
⁶⁵Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁶⁶INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
⁶⁷Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
⁶⁸Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁶⁹Molecular Oncology Laboratory, Hospital Clinico San Carlos, Madrid, Spain.
⁷⁰Center for Cancer Research, University of Sydney at Westmead Millennium Institute, Sydney, Australia; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia.
⁷¹Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁷²Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
⁷³Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
⁷⁴Oncogenetics Laboratory, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
⁷⁵Section of Biostatistics and Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
⁷⁶Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Basser Research Centre, Abramson Cancer Center, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
⁷⁷Department of Genetics, University of Pretoria, Pretoria, South Africa.
⁷⁸Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.
⁷⁹Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, UK.
⁸⁰Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Klinik Wiesbaden, Wiesbaden, Germany; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
⁸¹Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec, Canada.
⁸²Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
⁸³Institute of Biology and Molecular Genetics, Universidad de Valladolid (IBGM-UVA), Valladolid, Spain.
⁸⁴Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
⁸⁵Faculty of Medicine, University of Southampton, University Hospital Southampton, Southampton, UK.
⁸⁶Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
⁸⁷Department of Clinical Genetics, Lund University, Lund, Sweden.
⁸⁸Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
⁸⁹Institute of Human Genetics, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
⁹⁰Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
⁹¹Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
⁹²Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁹³University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany; David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, CA, USA.
⁹⁴Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain.
⁹⁵Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
⁹⁶Department of Cancer Epidemiology/Clinical Cancer Registry, Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany.
⁹⁷Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
⁹⁸Clinical Cancer Genetics, City of Hope, Duarte, CA, USA; New Mexico Cancer Center, Albuquerque, NM, USA.
⁹⁹Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Milan, Italy; Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
¹⁰⁰Molecular Diagnostics Laboratory, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece.
¹⁰¹Kansas IDeA Network of Biomedical Research Excellence Bioinformatics Core, The University of Kansas Cancer Center, Kansas City, KS, USA.
¹⁰²University of Pennsylvania, Philadelphia, PA, USA.
¹⁰³The Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer, Israel; Institute of Oncology, Sheba Medical Center, Tel-Hashomer, Israel.
¹⁰⁴Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
¹⁰⁵Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁰⁶Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.
¹⁰⁷Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
¹⁰⁸Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
¹⁰⁹Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, UCL, London, UK.
¹¹⁰Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
¹¹¹Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
¹¹²Cancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Glasgow, UK.
¹¹³Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
¹¹⁴Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
¹¹⁵Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
¹¹⁶Gynecological Oncology Unit, The Royal Marsden Hospital, London, UK.
¹¹⁷Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
¹¹⁸Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland.
¹¹⁹Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
¹²⁰Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
¹²¹INSERM U1018, CESP (Center for Research in Epidemiology and Population Health), Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France.
¹²²Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
¹²³University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany.
¹²⁴Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
¹²⁵Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
¹²⁶Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
¹²⁷Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹²⁸Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
¹²⁹Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Klinik Wiesbaden, Wiesbaden, Germany; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
¹³⁰Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
¹³¹Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
¹³²University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center, Erlangen, Germany.
¹³³Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Klinik Wiesbaden, Wiesbaden, Germany; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
¹³⁴Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
¹³⁵Clinical Cancer Genetics, City of Hope, Duarte, CA, USA.
¹³⁶Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
¹³⁷Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
¹³⁸Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark; Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
¹³⁹Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
¹⁴⁰Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
¹⁴¹Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
¹⁴²Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
¹⁴³N.N. Petrov Institute of Oncology, St. Petersburg, Russia.
¹⁴⁴Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
¹⁴⁵Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
¹⁴⁶Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, State Research Centre Institute for Innovative Medicine, Vilnius, Lithuania.
¹⁴⁷Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland.
¹⁴⁸Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
¹⁴⁹Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
¹⁵⁰Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
¹⁵¹Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland.
¹⁵²Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹⁵³Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
¹⁵⁴School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland; Jyväskylä Central Hospital, Jyväskylä, Finland.
¹⁵⁵Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
¹⁵⁶Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, Canada; Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada; Department of Oncology, University of Calgary, Calgary, Alberta, Canada.
¹⁵⁷School of Medicine, National University of Ireland, Galway, Ireland.
¹⁵⁸Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands.
¹⁵⁹Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
¹⁶⁰Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
¹⁶¹Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹⁶²Molecular Diagnostics Laboratory, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece.
¹⁶³Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
¹⁶⁴Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway.
¹⁶⁵Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway; Faculty of Medicine (Faculty Division Ahus), Universitetet i Oslo, Norway.
¹⁶⁶Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁶⁷Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
¹⁶⁸The Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer, Israel; Institute of Oncology, Sheba Medical Center, Tel-Hashomer, Israel.
¹⁶⁹Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Belgium; Vesalius Research Center (VRC), VIB, Leuven, Belgium.
¹⁷⁰Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium; Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
¹⁷¹Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
¹⁷²Genetic and Molecular Epidemiology Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
¹⁷³Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France.
¹⁷⁴Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain.
¹⁷⁵Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada.
¹⁷⁶Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
¹⁷⁷Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
¹⁷⁸Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
¹⁷⁹Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
¹⁸⁰Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
¹⁸¹College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, USA.
¹⁸²Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
¹⁸³Center for Individualized Medicine, Mayo Clinic, Scottsdale, AZ, USA.
¹⁸⁴Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland.
¹⁸⁵Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
¹⁸⁶Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
¹⁸⁷Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
¹⁸⁸Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
¹⁸⁹Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
¹⁹⁰Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
¹⁹¹Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
¹⁹²Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
¹⁹³Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Milan, Italy; Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
¹⁹⁴Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
¹⁹⁵Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
¹⁹⁶Department of Gynecology, Radboud University Medical Centre, Nijmegen, The Netherlands.
¹⁹⁷Laboratoire de Diagnostic Génétique et Service d'Onco-hématologie, Hopitaux Universitaire de Strasbourg, CHRU Nouvel Hôpital Civil, Strasbourg, France.
¹⁹⁸INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
¹⁹⁹Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
²⁰⁰Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA.
²⁰¹Anatomical Pathology, The Alfred Hospital, Melbourne, Australia.
²⁰²Institute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, UK.
²⁰³Department of Gynecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
²⁰⁴INSERM U1018, CESP (Center for Research in Epidemiology and Population Health), Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France.
²⁰⁵Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain.
²⁰⁶Department of Surgical Gynecology and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland.
²⁰⁷Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, UCL, London, UK.
²⁰⁸Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
²⁰⁹School of Medicine, National University of Ireland, Galway, Ireland.
²¹⁰Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia.
²¹¹Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Women's Cancer Research Program, Magee-Women's Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
²¹²Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
²¹³Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
²¹⁴Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
²¹⁵Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
²¹⁶Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
²¹⁷Women's College Research Institute, University of Toronto, Toronto, ON, Canada.
²¹⁸Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Basser Research Centre, Abramson Cancer Center, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
²¹⁹The University of Texas School of Public Health, Houston, TX, USA.
²²⁰Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
²²¹Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
²²²Multidisciplinary Breast Center, University Hospital Leuven, University of Leuven, Belgium.
²²³Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
²²⁴Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
²²⁵Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
²²⁶Department of Medicine and Institute for Human Genetics, University of California, San Francisco, CA, USA.
²²⁷Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
²²⁸Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
²²⁹Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
²³⁰Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, IL, USA.
²³¹Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
²³²Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
²³³University of Groningen, University Medical Center, Department of Genetics, Groningen, The Netherlands.
²³⁴Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
²³⁵Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
²³⁶Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
²³⁷Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain; Genetic and Molecular Epidemiology Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
²³⁸Department of Molecular Medicine, Sapienza University, Rome, Italy.
²³⁹Cancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Glasgow, UK.
²⁴⁰Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
²⁴¹Section of Molecular Diagnostics, Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
²⁴²Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori (INT), Milan, Italy.
²⁴³Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR, USA; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
²⁴⁴Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
²⁴⁵Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
²⁴⁶Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
²⁴⁷Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Milan, Italy.
²⁴⁸Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, UK.
²⁴⁹Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
²⁵⁰Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Medicine, St Vincent's Hospital, The University of Melbourne, Victoria, Australia.
²⁵¹NRG Oncology Statistics and Data Management Center, Buffalo, NY, USA.
²⁵²Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
²⁵³Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
²⁵⁴Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
²⁵⁵Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Channing Division of Network Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
²⁵⁶Center for Medical Genetics, Ghent University, Ghent, Belgium.
²⁵⁷Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics, University of Oulu, Oulu University Hospital, Oulu, Finland; Biocenter Oulu, University of Oulu, Oulu, Finland.
²⁵⁸Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori (INT), Milan, Italy.
²⁵⁹Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
²⁶⁰Basser Research Centre, Abramson Cancer Center, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA; Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
²⁶¹Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, UK.
²⁶²Clalit National Israeli Cancer Control Center, Haifa, Israel; Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion, Haifa, Israel.
²⁶³Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
²⁶⁴Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
²⁶⁵NorthShore University Health System, University of Chicago, Evanston, IL, USA.
²⁶⁶Molecular Oncology Laboratory, Hospital Clinico San Carlos, Madrid, Spain.
²⁶⁷Department of Epidemiology, University of Washington, Seattle, WA, USA; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
²⁶⁸Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA.
²⁶⁹Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
²⁷⁰Department of Gynecology, Jena University Hospital, Jena, Germany.
²⁷¹Ohio State University, Columbus, OH, USA.
²⁷²Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway.
²⁷³Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, London, UK.
²⁷⁴Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA; Cancer Prevention, Detection and Control Research Program, Duke Cancer Institute, Durham, NC, USA.
²⁷⁵Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
²⁷⁶Centre of Familial Breast and Ovarian Cancer, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany; Centre for Molecular Medicine Cologne (CMMC), University Hospital of Cologne, Cologne, Germany.
²⁷⁷Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
²⁷⁸Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey, UK.
²⁷⁹University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany.
²⁸⁰Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
²⁸¹Institut für Humangenetik Wiesbaden, Wiesbaden, Germany.
²⁸²Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori (INT), Milan, Italy.
²⁸³Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
²⁸⁴Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
²⁸⁵Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
²⁸⁶Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
²⁸⁷Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
²⁸⁸Department of Gynecological Oncology, Glasgow Royal Infirmary, Glasgow, UK.
²⁸⁹Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA.
²⁹⁰Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec, Canada.
²⁹¹Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
²⁹²INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, Centre Léon Bérard, Lyon, France.
²⁹³Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Belgium; Vesalius Research Center (VRC), VIB, Leuven, Belgium.
²⁹⁴Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
²⁹⁵Department of Clinical Genetics, University and Regional Laboratories, Lund University Hospital, Lund, Sweden.
²⁹⁶Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
²⁹⁷Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec, Canada.
²⁹⁸Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia.
²⁹⁹Saarland Cancer Registry, Saarbrücken, Germany.
³⁰⁰Institut Curie, Department of Tumour Biology, Paris, France; Institut Curie, INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, France.
³⁰¹Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
³⁰²Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey, UK; Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey, UK.
³⁰³Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway.
³⁰⁴Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
³⁰⁵Department of Genetics, Portuguese Oncology Institute, Porto, Portugal; Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal.
³⁰⁶Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA, USA; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
³⁰⁷Department of Epidemiology, Columbia University, New York, NY, USA.
³⁰⁸Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
³⁰⁹Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
³¹⁰Latvian Biomedical Research and Study Centre, Riga, Latvia.
³¹¹Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada.
³¹²Divison of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
³¹³Department of Surgical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
³¹⁴Welcome Trust Centre for Human Genetics, University of Oxford, UK; Oxford Biomedical Research Centre, University of Oxford, UK.
³¹⁵Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany; Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.
³¹⁶INSERM U1018, CESP (Center for Research in Epidemiology and Population Health), Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France.
³¹⁷Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia.
³¹⁸Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
³¹⁹Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Channing Division of Network Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
³²⁰Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
³²¹Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
³²²Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
³²³Department of Gynecology, Radboud University Medical Centre, Nijmegen, The Netherlands.
³²⁴Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
³²⁵Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
³²⁶Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
³²⁷Department of Gynecology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
³²⁸Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium; Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
³²⁹Department of Genetics, University of Pretoria, Pretoria, South Africa.
³³⁰Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium; Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
³³¹Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
³³²Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
³³³Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
³³⁴Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
³³⁵Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
³³⁶Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
³³⁷Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
³³⁸Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany.
³³⁹Centre of Familial Breast and Ovarian Cancer, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany; Centre for Molecular Medicine Cologne (CMMC), University Hospital of Cologne, Cologne, Germany.
³⁴⁰Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
³⁴¹Clinical Cancer Genetics, City of Hope, Duarte, CA, USA.
³⁴²Multidisciplinary Breast Center, University Hospital Leuven, University of Leuven, Belgium.
³⁴³Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
³⁴⁴Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA.
³⁴⁵Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
³⁴⁶Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics, University of Oulu, Oulu University Hospital, Oulu, Finland; Biocenter Oulu, University of Oulu, Oulu, Finland.
³⁴⁷Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
³⁴⁸Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³⁴⁹Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
³⁵⁰Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori (INT), Milan, Italy.
³⁵¹Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain.
³⁵²Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
³⁵³Department of Epidemiology, Center for Cancer Genetics Research and Prevention, School of Medicine, University of California Irvine, Irvine, CA, USA.
³⁵⁴Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
³⁵⁵Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
³⁵⁶Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
³⁵⁷Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
³⁵⁸Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.